{"id":19263,"date":"2023-03-30T12:23:46","date_gmt":"2023-03-30T12:23:46","guid":{"rendered":"https:\/\/clinlabint.com\/?p=19263"},"modified":"2023-03-30T12:23:46","modified_gmt":"2023-03-30T12:23:46","slug":"alcediag-and-synlab-join-forces-in-europe-to-fight-diagnostic-delay-of-bipolar-disorder-with-the-edit-b-test","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/alcediag-and-synlab-join-forces-in-europe-to-fight-diagnostic-delay-of-bipolar-disorder-with-the-edit-b-test\/","title":{"rendered":"ALCEDIAG and SYNLAB join forces in Europe to fight diagnostic delay of bipolar disorder with the EDIT-B\u2122 test"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

ALCEDIAG and SYNLAB join forces in Europe to fight diagnostic delay of bipolar disorder with the EDIT-B\u2122 test<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n
\"\"<\/div><\/div><\/div>
\n
    \n
  • \n

    An estimated 2.3% of the European population is affected by bipolar disorder (BD)[1]<\/sup>, a largely underestimated figure, since an average of 8-10 years passes between the appearance of symptoms and diagnosis[2]<\/sup><\/h3>\n<\/li>\n
  • \n

    To date, the diagnosis of BD is based on a psychiatric clinical examination of the patient, made by a psychiatrist.<\/h3>\n<\/li>\n
  • \n

    BD is so difficult to diagnose because it is often confused with depression. Misdiagnosed patients may receive inappropriate treatment, which may even worsen their health condition.<\/h3>\n<\/li>\n
  • \n

    To significantly reduce this diagnosis wondering, ALCEDIAG and SYNLAB are announcing, on the occasion of the 31st<\/sup> EPA congress, the availability of EDIT-B\u2122, the world’s first CE-marked in-vitro blood test designed to differentiate BD from depression.<\/h3>\n<\/li>\n<\/ul>\n

    <\/p>\n

    EDIT-B\u2122: a reliable, validated and rapid biological response to reduce the diagnostic delay and address an unmet medical need.<\/b><\/h4>\n

    ALCEDIAG and SYNLAB are making EDIT-B\u2122\u00a0, based on RNA editing and AI, available to specialized healthcare professionals and their patients in Europe.<\/p>\n<\/div><\/section>
    \n